Hong Lv
4PUBLICATIONS
29CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Apr 24, 2025
USP14-IMP2-CXCL2 axis in tumor-associated macrophages facilitates resistance to anti-PD-1 therapy in gastric cancer by recruiting myeloid-derived suppressor cells.Li You, Qian Wang, Tianxue Zhang
|Aug 26, 2024
Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies.Yu-Wei Li, Lei-Jie Dai, Xiang-Rong Wu
|Feb 12, 2024
Response to anti-HER2 neoadjuvant chemotherapy in HER2-positive invasive breast cancers with different HER2 FISH patterns.Hong Lv, Qian-Ming Bai, Ming Li
|Aug 09, 2023
Invasive Breast Cancer with HER2 ≥4.0 and <6.0: Risk Classification and Molecular Typing by a 21-Gene Expression Assay and MammaPrint Plus BluePrint Testing.Qianming Bai, Hong Lv, Longlong Bao
Pageof 1
Frequent Collaborators
1 joint publications
Qianming Bai
1 joint publications
Ruo-Hong Shui
1 joint publications
Xiao-Li Xu
1 joint publications
Bao-Hua Yu
1 joint publications
Rui Bi
1 joint publications
Xiao-Yan Zhou
1 joint publications
Yu-Wei Li
1 joint publications
Lei-Jie Dai
1 joint publications
Xiang-Rong Wu
1 joint publications
Shen Zhao
